PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1528976
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1528976
Penile Implants Market Size - By Implant Type (Inflatable, Non-inflatable), Material (Silicone, Bioflex), End-use (Hospitals, Ambulatory Surgical Centres) & Global Forecast, 2024 - 2032
Penile implants market size is projected to witness a 4.7% CAGR between 2024 and 2032 driven by the rising prevalence of erectile dysfunction (ED) globally. As per reports, it is projected that by 2025, erectile dysfunction will affect 322 million men worldwide. This growing burden of ED can result from various factors including aging, cardiovascular diseases, diabetes, hypertension, and lifestyle choices, such as smoking and alcohol consumption. With the aging global population and the increasing incidence of these health conditions, the demand for effective ED treatments, including penile implants, will rise correspondingly.
The growing healthcare infrastructure in emerging economies, coupled with increasing healthcare expenditure are fueling the market expansion. The shift towards destigmatizing ED and promoting open discussions about sexual health is encouraging more men to seek treatment. As more individuals are gaining access to healthcare services, the diagnosis and treatment rates of ED are expected to rise, leading to higher product demand.
The penile implants industry is classified into implant type, material, end-use and region.
Based on implant type, the market size from the non-inflatable segment is projected to witness substantial growth through 2032 due to simplicity, reliability, and ease of use compared to inflatable implants. Non-inflatable penile implants offer a straightforward surgical procedure with a lower risk of mechanical failure. These implants also provide a constant state of readiness for sexual activity while eliminating the need for complex inflation mechanisms.
Penile implants market from the ambulatory surgical centers segment is predicted to record a high revenue share by 2032 owing to the efficiency, convenience, and cost-effectiveness offered by these facilities. Ambulatory surgical centers (ASCs) provide specialized, outpatient surgical care, allowing patients to undergo penile implant procedures in a less intimidating, more patient-friendly environment compared to traditional hospitals. These settings also offer results in shorter procedure times, reduced hospital stays, and lower overall healthcare costs.
Asia Pacific penile implants industry size will grow significantly through 2032 driven by rising healthcare awareness, increasing disposable incomes, and the growing prevalence of lifestyle diseases leading to erectile dysfunction. The expanding middle-class population is becoming more health-conscious and willing to invest in advanced medical treatments. Rapid urbanization, and changing lifestyles are further contributing to the higher incidences of diabetes, hypertension, and other conditions associated with ED, adding to the regional market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of erectile dysfunction
- 3.2.1.2 Technological advancement
- 3.2.1.3 Growing prevalence of chronic diseases
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost associated with the procedure
- 3.2.2.2 Presence of alternative drug treatment
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Implant Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Inflatable
- 5.3 Non-inflatable
Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Silicone
- 6.3 Bioflex
- 6.4 Other materials
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centres
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Boston Scientific Corporation
- 9.2 Coloplast Corp
- 9.3 Dornier MedTech
- 9.4 Eska Medical Gmbh
- 9.5 Giant Medical LLC
- 9.6 GT Urological, LLC
- 9.7 Owen Mumford Ltd.
- 9.8 Pos-T-Vac, Inc.
- 9.9 Promedon
- 9.10 Reflexonic LLC
- 9.11 Rigicon Inc.
- 9.12 Silimed
- 9.13 Sofregen Medical Inc.
- 9.14 Uroplasty Inc.
- 9.15 Zephyr Surgical Implants
